- Home
- BWMN vs MLTX Comparison
BWMN vs MLTX Comparison
Compare BWMN & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMN
- MLTX
- Stock Information
- Founded
- BWMN 1995
- MLTX 2021
- Country
- BWMN United States
- MLTX Switzerland
- Employees
- BWMN N/A
- MLTX N/A
- Industry
- BWMN Military/Government/Technical
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- BWMN Consumer Discretionary
- MLTX Health Care
- Exchange
- BWMN Nasdaq
- MLTX Nasdaq
- Market Cap
- BWMN 737.1M
- MLTX 595.6M
- IPO Year
- BWMN 2021
- MLTX N/A
- Fundamental
- Price
- BWMN $43.01
- MLTX $10.20
- Analyst Decision
- BWMN Strong Buy
- MLTX Buy
- Analyst Count
- BWMN 3
- MLTX 9
- Target Price
- BWMN $38.17
- MLTX $36.78
- AVG Volume (30 Days)
- BWMN 80.8K
- MLTX 4.5M
- Earning Date
- BWMN 11-05-2025
- MLTX 11-07-2025
- Dividend Yield
- BWMN N/A
- MLTX N/A
- EPS Growth
- BWMN N/A
- MLTX N/A
- EPS
- BWMN 0.61
- MLTX N/A
- Revenue
- BWMN $462,176,000.00
- MLTX N/A
- Revenue This Year
- BWMN $18.04
- MLTX N/A
- Revenue Next Year
- BWMN $6.17
- MLTX N/A
- P/E Ratio
- BWMN $70.28
- MLTX N/A
- Revenue Growth
- BWMN 19.48
- MLTX N/A
- 52 Week Low
- BWMN $17.90
- MLTX $5.95
- 52 Week High
- BWMN $45.83
- MLTX $62.75
- Technical
- Relative Strength Index (RSI)
- BWMN 51.50
- MLTX 30.02
- Support Level
- BWMN $42.72
- MLTX $9.37
- Resistance Level
- BWMN $45.83
- MLTX $10.40
- Average True Range (ATR)
- BWMN 1.49
- MLTX 0.53
- MACD
- BWMN -0.08
- MLTX 1.66
- Stochastic Oscillator
- BWMN 33.65
- MLTX 80.14
About BWMN Bowman Consulting Group Ltd.
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.